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Introduction 1
Caffeine is a legal and socially acceptable drug and as such is commonly found in most people's 2 diets. Caffeine's effects have been determined in a number of physiological systems including 3 the cardiovascular, endocrine and central nervous systems (reviewed by Benowitz 1990) . 4 However, little research has focused on how caffeine may affect various aspects of the immune be taken into account that there are significant differences in caffeine metabolism and the 10 plasma half-life of caffeine (rodents: 0.7-1.2 h vs. humans: 4-6 h) between rodents and humans 11 that may in fact limit extrapolation of findings from non-human models. To the authors knowledge no study to date has investigated the effect of caffeine on human 11 lymphocyte activation in response to antigenic stimulation. Therefore, the aim of this study 12 was to investigate the effect of a high and low dose of caffeine on antigen-stimulated 13 lymphocyte (CD4 + , CD8 + and CD3 -CD56 + ) activation over a period of 3.5 h, as assessed by 14 expression of CD69.
16

Materials and methods
17
Participants and trial protocol 18 Six healthy recreationally active participants [age 25 (2) years; weight 75 (7) kg] gave written 19 informed consent to take part in the study, which was approved by the local Ethical Advisory 20 Committee. 21 Participants completed an extensive health-screening questionnaire along with a physical 22 activity questionnaire during their initial visit to the laboratory to ascertain if they were suitable 1 for the study. Any participants that were currently on medication or had reported symptoms of 2 infection in the 4 weeks prior to the study were excluded. Participants' habitual caffeine 3 consumption was also recorded at the beginning of each study using a caffeine consumption 4 questionnaire to classify participants as low, moderate or high habitual caffeine users. On the 5 day of each main trial, a subsequent health-screening questionnaire was administered to 6 confirm that participants were not experiencing any symptoms of URTI and were happy to take 7 part in the study. Daily caffeine intake amongst participants was varied and ranged from 40 -8 220 mg.day -1 , with an average intake of 120 ± 85 mg.day -1 . Two subjects were characterised as 9 as light users (< 50 mg. day -1 ) and the other 4 as moderate users (50 -250 mg. day -1 ). 10 11 To standardize nutritional status, participants completed a 24 h food diary the day before the 12 first main trial and were asked to follow this during the 24 h preceding the second and third Serum caffeine and plasma adrenaline 10 Whole blood collected into a plain monovette (5.5 ml) was left to clot for 1 h before centrifuged 11 at 1500 g for 10 min at 4C. Heparinized plasma was obtained from blood collected into a 12 lithium heparin monovette (7.5 ml). Samples were spun at 1500 g for 10 min at 4C within 5 13 min of collection. Serum caffeine and plasma adrenaline concentration were measured as 14 previously described (Fletcher and Bishop 2012). Serum caffeine concentration at 1 h, 2.5 h and 3.5 h after caffeine ingestion was higher on 6CAF 6 than 2CAF and PLA and higher on 2CAF than PLA (F=24.058, all P=0.000; Table 1 ). At 1 h and 2.5 7 h after caffeine ingestion, plasma adrenaline concentration was higher on 6CAF than PLA 8 (F=9.273, 1 h, P=0.038; 2.5 h P=0.003; Table 1 ). Neither caffeine ingestion nor time of day 9 affected the number of CD4 + and CD8 + cells within the circulating lymphocyte population (Table   10 1). However, the number of CD3 -CD56 + cells was higher 1 h and 2.5 h after caffeine ingestion on 11 6CAF than on PLA and 2CAF (F=5.806, 1 h: 6CAF v PLA P=0.002, 6CAF v 2CAF P=0.042; 2.5 h:
12
6CAF v PLA P=0.046, 6CAF v 2CAF P=0.036; Table 1 ). There was no effect of caffeine on the 13 number of unstimulated CD4 + , CD8 + and CD3 -CD56 + cells or antigen-stimulated (both doses) 14 CD4 + and CD8 + cells expressing CD69 (unstimulated, data in Supplementary Table 1 ; antigen-15 stimulated, Table 2 ). A high dose of caffeine increased the number of antigen-stimulated CD3 -16 CD56 + cells expressing CD69 1 h following caffeine ingestion compared with PLA (6CAF 1:4000 v 17 PLA 1:4000, F=2.536, P=0.021; Fig. 1 ). Neither caffeine ingestion nor time of day affected the 18 geometric mean fluorescence intensity (GMFI) of CD69 expression on unstimulated 19 ( Supplementary Table 1 ) or antigen-stimulated CD4 + , CD8 + and CD3 -CD56 + cells (Table 3) . antagonist. It should be noted that plasma adenosine was not measured in this study and as 10 such this explanation is only speculation. However, support comes from the exercise literature 11 where prolonged intensive exercise, which is known to markedly increase plasma adenosine In summary, this is the first study in humans to determine that a high (6 mg•kg -1 ) but not a low 19 (2 mg•kg -1 ) dose of caffeine increases the number of NK cells expressing the early activation 
